866-997-4948(US-Canada Toll Free)

United States Cancer Treatment Drugs Market Report 2016

Published By :

QYResearch

Published Date : Sep 2016

Category :

Cancer

No. of Pages : 118 Pages

Notes:
Sales, means the sales volume of Cancer Treatment Drugs
Revenue, means the sales value of Cancer Treatment Drugs

This report studies sales (consumption) of Cancer Treatment Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Dendreon
GlaxoSmithKline
Merck
Sanofi
Vaccinogen
Vaxon Biotech
Vical
Aduro BioTech
Advantagene
Advaxis
Agenus
AlphaVax
Altor BioScience
Amgen
Antigen Express
Argos Therapeutics
Biothera
Bristol-Myers Squibb
Celldex Therapeutics
Cel-Sci
CureVac
Cytos
Galena Biopharma
Gradalis
Heat Biologics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Cancer Treatment Drugs in each application, can be divided into
Application 1
Application 2
Application 3

Table of Contents

United States Cancer Treatment Drugs Market Report 2016
1 Cancer Treatment Drugs Overview
1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Classification of Cancer Treatment Drugs
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Cancer Treatment Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Treatment Drugs (2011-2021)
1.4.1 United States Cancer Treatment Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)

2 United States Cancer Treatment Drugs Competition by Manufacturers
2.1 United States Cancer Treatment Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cancer Treatment Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cancer Treatment Drugs Average Price by Manufactures (2015 and 2016)
2.4 Cancer Treatment Drugs Market Competitive Situation and Trends
2.4.1 Cancer Treatment Drugs Market Concentration Rate
2.4.2 Cancer Treatment Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Cancer Treatment Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Cancer Treatment Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Cancer Treatment Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Cancer Treatment Drugs Price by Type (2011-2016)
3.4 United States Cancer Treatment Drugs Sales Growth Rate by Type (2011-2016)

4 United States Cancer Treatment Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Cancer Treatment Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Cancer Treatment Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 United States Cancer Treatment Drugs Manufacturers Profiles/Analysis
5.1 Dendreon
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Cancer Treatment Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Dendreon Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline
5.2.2 Cancer Treatment Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 GlaxoSmithKline Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Merck
5.3.2 Cancer Treatment Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Merck Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Sanofi
5.4.2 Cancer Treatment Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Vaccinogen
5.5.2 Cancer Treatment Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Vaccinogen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Vaxon Biotech
5.6.2 Cancer Treatment Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Vaxon Biotech Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Vical
5.7.2 Cancer Treatment Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Vical Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Aduro BioTech
5.8.2 Cancer Treatment Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Aduro BioTech Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Advantagene
5.9.2 Cancer Treatment Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Advantagene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Advaxis
5.10.2 Cancer Treatment Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Advaxis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Agenus
5.12 AlphaVax
5.13 Altor BioScience
5.14 Amgen
5.15 Antigen Express
5.16 Argos Therapeutics
5.17 Biothera
5.18 Bristol-Myers Squibb
5.19 Celldex Therapeutics
5.20 Cel-Sci
5.21 CureVac
5.22 Cytos
5.23 Galena Biopharma
5.24 Gradalis
5.25 Heat Biologics

6 Cancer Treatment Drugs Manufacturing Cost Analysis
6.1 Cancer Treatment Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cancer Treatment Drugs

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Cancer Treatment Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 United States Cancer Treatment Drugs Market Forecast (2016-2021)
10.1 United States Cancer Treatment Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Cancer Treatment Drugs Sales Forecast by Type (2016-2021)
10.3 United States Cancer Treatment Drugs Sales Forecast by Application (2016-2021)
10.4 Cancer Treatment Drugs Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Cancer Treatment Drugs
Table Classification of Cancer Treatment Drugs
Figure United States Sales Market Share of Cancer Treatment Drugs by Type in 2015
Table Application of Cancer Treatment Drugs
Figure United States Sales Market Share of Cancer Treatment Drugs by Application in 2015
Figure United States Cancer Treatment Drugs Sales and Growth Rate (2011-2021)
Figure United States Cancer Treatment Drugs Revenue and Growth Rate (2011-2021)
Table United States Cancer Treatment Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Treatment Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Treatment Drugs Sales Share by Manufacturers
Figure 2016 Cancer Treatment Drugs Sales Share by Manufacturers
Table United States Cancer Treatment Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Treatment Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Treatment Drugs Revenue Share by Manufacturers
Table 2016 United States Cancer Treatment Drugs Revenue Share by Manufacturers
Table United States Market Cancer Treatment Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Treatment Drugs Average Price of Key Manufacturers in 2015
Figure Cancer Treatment Drugs Market Share of Top 3 Manufacturers
Figure Cancer Treatment Drugs Market Share of Top 5 Manufacturers
Table United States Cancer Treatment Drugs Sales by Type (2011-2016)
Table United States Cancer Treatment Drugs Sales Share by Type (2011-2016)
Figure United States Cancer Treatment Drugs Sales Market Share by Type in 2015
Table United States Cancer Treatment Drugs Revenue and Market Share by Type (2011-2016)
Table United States Cancer Treatment Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Treatment Drugs by Type (2011-2016)
Table United States Cancer Treatment Drugs Price by Type (2011-2016)
Figure United States Cancer Treatment Drugs Sales Growth Rate by Type (2011-2016)
Table United States Cancer Treatment Drugs Sales by Application (2011-2016)
Table United States Cancer Treatment Drugs Sales Market Share by Application (2011-2016)
Figure United States Cancer Treatment Drugs Sales Market Share by Application in 2015
Table United States Cancer Treatment Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Cancer Treatment Drugs Sales Growth Rate by Application (2011-2016)
Table Dendreon Basic Information List
Table Dendreon Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Cancer Treatment Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Vaccinogen Basic Information List
Table Vaccinogen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaccinogen Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Vaxon Biotech Basic Information List
Table Vaxon Biotech Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaxon Biotech Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Vical Basic Information List
Table Vical Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Aduro BioTech Basic Information List
Table Aduro BioTech Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aduro BioTech Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Advantagene Basic Information List
Table Advantagene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advantagene Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Advaxis Basic Information List
Table Advaxis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advaxis Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Agenus Basic Information List
Table Agenus Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agenus Cancer Treatment Drugs Sales Market Share (2011-2016)
Table AlphaVax Basic Information List
Table AlphaVax Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AlphaVax Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Altor BioScience Basic Information List
Table Altor BioScience Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Altor BioScience Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Antigen Express Basic Information List
Table Antigen Express Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Antigen Express Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Argos Therapeutics Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Biothera Basic Information List
Table Biothera Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biothera Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celldex Therapeutics Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Cel-Sci Basic Information List
Table Cel-Sci Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cel-Sci Cancer Treatment Drugs Sales Market Share (2011-2016)
Table CureVac Basic Information List
Table CureVac Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table CureVac Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Cytos Basic Information List
Table Cytos Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cytos Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Galena Biopharma Basic Information List
Table Galena Biopharma Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galena Biopharma Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Gradalis Basic Information List
Table Gradalis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gradalis Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Heat Biologics Basic Information List
Table Heat Biologics Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Heat Biologics Cancer Treatment Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Treatment Drugs
Figure Manufacturing Process Analysis of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Industrial Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2015
Table Major Buyers of Cancer Treatment Drugs
Table Distributors/Traders List
Figure United States Cancer Treatment Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Cancer Treatment Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Cancer Treatment Drugs Production Forecast by Type (2016-2021)
Table United States Cancer Treatment Drugs Consumption Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *